SinoMab BioScience Limited (3681.HK)

HKD 1.58

(0.0%)

Operating Expenses Summary of SinoMab BioScience Limited

SinoMab BioScience Limited's latest annual operating expenses in 2023 was 422 Thousand CNY , down -21.45% from previous year.
SinoMab BioScience Limited's latest quarterly operating expenses in 2024 Q2 was 89.24 Million CNY , down 0.0% from previous quarter.
SinoMab BioScience Limited reported a annual operating expenses of 292.81 Million CNY in annual operating expenses 2022, down -10.12% from previous year.
SinoMab BioScience Limited reported a annual operating expenses of 325.76 Million CNY in annual operating expenses 2021, up 116.75% from previous year.
SinoMab BioScience Limited reported a quarterly operating expenses of 116.07 Million CNY for 2023 Q4, down 0.0% from previous quarter.
SinoMab BioScience Limited reported a quarterly operating expenses of 138.42 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of SinoMab BioScience Limited (2023 - 2017)

Historical Annual Operating Expenses of SinoMab BioScience Limited (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	422 Thousand CNY	-21.45%
2022	292.81 Million CNY	-10.12%
2021	325.76 Million CNY	116.75%
2020	150.29 Million CNY	-45.52%
2019	275.88 Million CNY	403.45%
2018	54.79 Million CNY	38.4%
2017	39.59 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	89.24 Million CNY	0.0%
2023 Q4	116.07 Million CNY	0.0%
2023 Q2	138.42 Million CNY	0.0%
2023 FY	229.99 Million CNY	-21.45%
2022 FY	292.81 Million CNY	-10.12%
2022 Q4	143.7 Million CNY	0.0%
2022 Q2	149.1 Million CNY	0.0%
2021 Q2	111.9 Million CNY	0.0%
2021 Q4	213.85 Million CNY	0.0%
2021 FY	325.76 Million CNY	116.75%
2020 Q2	79.31 Million CNY	0.0%
2020 FY	150.29 Million CNY	-45.52%
2020 Q4	70.97 Million CNY	0.0%
2019 Q2	45.04 Million CNY	165.3%
2019 FY	275.88 Million CNY	403.45%
2019 Q4	231.89 Million CNY	0.0%
2019 Q1	-68.97 Million CNY	0.0%
2018 Q1	-13.69 Million CNY	0.0%
2018 FY	54.79 Million CNY	38.4%
2018 Q4	-68.97 Million CNY	0.0%
2018 Q2	-13.69 Million CNY	0.0%
2017 FY	39.59 Million CNY	0.0%
2017 Q1	-9.89 Million CNY	0.0%
2017 Q2	-9.89 Million CNY	0.0%
2017 Q4	-13.69 Million CNY	0.0%
2016 Q4	-9.89 Million CNY	0.0%

Peer Operating Expenses Comparison of SinoMab BioScience Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	99.87%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	99.943%